Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Extracellular Vesicles (EVs: Exosomes and Microvesicles): Research, Diagnostics and Therapeutics Applications

Navneet Dogra's Biography



Navneet Dogra, Researcher, IBM

Navneet Dogra is a research scientist in the Nanobiotechnology group at IBM. In colaboration with major cancer hospitals in New York City, Navneet is developing Lab-on-a-chip device for early diagnosis of cancer. In a recent breakthrough, Navneet and his team have developed a gadget that can detect cancer biomarkers at unprecedented scale. Prior to Joining IBM in 2016, Navneet was a Post-Doctoral Associate at Yale University. Apart from publishing in research journals, he has published his paintings/cartoons in many magazines and news papers.

Navneet Dogra Image

On-Chip Liquid Biopsy: Progress in Isolation of Exosomes and Their RNA Sequencing For Prognosis of Prostate Cancer

Thursday, 29 March 2018 at 16:00

Add to Calendar ▼2018-03-29 16:00:002018-03-29 17:00:00Europe/LondonOn-Chip Liquid Biopsy: Progress in Isolation of Exosomes and Their RNA Sequencing For Prognosis of Prostate CancerSELECTBIOenquiries@selectbiosciences.com

Exosomes are an exciting target for “liquid biopsies”. However, isolation of exosomes and reproducible detection of their biomarkers remains an ongoing challenge. We have developed a microfluidic nanoscale DLD (Deterministic lateral displacement) device that brings capabilities with size based sorting of colloidal particles at the tens of nanometers scale (Wunsch et al. , Nature Nanotechnology 2016). I will present our most recent findings using RNA sequencing of cancer cell lines and patient samples.


Add to Calendar ▼2018-03-28 00:00:002018-03-29 00:00:00Europe/LondonExtracellular Vesicles (EVs: Exosomes and Microvesicles): Research, Diagnostics and Therapeutics ApplicationsSELECTBIOenquiries@selectbiosciences.com